(Q33598697)

28 July 2017

title

Sulfonate-containing thiiranes as selective gelatinase inhibitors (English)

1 reference

28 July 2017

Leticia I Llarrull

5

0 references

Mijoon Lee

object named as

Mijoon Lee

2

0 references

Mayland Chang

8

object named as

Mayland Chang

1 reference

28 July 2017

7

Shahriar Mobashery

1 reference

28 July 2017

6

Marta Toth

1 reference

28 July 2017

Sebastian A Testero

1

1 reference

28 July 2017

Rachel T Staran

3

1 reference

28 July 2017

Mana Espahbodi

4

1 reference

28 July 2017

publication date

13 December 2010

1 reference

ACS Medicinal Chemistry Letters

28 July 2017

published in

1 reference

28 July 2017

volume

2

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

177-181

1 reference

Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility.

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4018095

Matrix metalloproteinase 2 (MMP2) inhibition: DFT and QM/MM studies of the deprotonation-initialized ring-opening reaction of the sulfoxide analogue of SB-3CT.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4018095

Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4018095

Matrix metalloproteinase 2 inhibition: combined quantum mechanics and molecular mechanics studies of the inhibition mechanism of (4-phenoxyphenylsulfonyl)methylthiirane and its oxirane analogue.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4018095

To bind zinc or not to bind zinc: An examination of innovative approaches to improved metalloproteinase inhibition

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4018095

Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4018095

DFT studies of the ring-opening mechanism of SB-3CT, a potent inhibitor of matrix metalloproteinase 2.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4018095

A potent gelatinase inhibitor with anti-tumor-invasive activity and its metabolic disposition

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4018095

Progress in the development of matrix metalloproteinase inhibitors

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4018095

Recent advances in MMP inhibitor design

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4018095

Extracellular matrix remodelling: the role of matrix metalloproteinases

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4018095

New functions for the matrix metalloproteinases in cancer progression

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4018095

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4018095

Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4018095

Matrix metalloproteinases: structures, evolution, and diversification

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4018095

Metabolism of a highly selective gelatinase inhibitor generates active metabolite

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4018095

Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4018095

Design, synthesis, and characterization of potent, slow-binding inhibitors that are selective for gelatinases

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4018095

Potent mechanism-based inhibitors for matrix metalloproteinases

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24900296

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Synthesis of chiral 2-(4-phenoxyphenylsulfonylmethyl)thiiranes as selective gelatinase inhibitors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24900296

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1021/ML100254E

1 reference

28 July 2017

1 reference

28 July 2017

1 reference